Aliases & Classifications for Dysentery

MalaCards integrated aliases for Dysentery:

Name: Dysentery 12 41 14 69
Infectious Diarrhea 12 51 59


Summaries for Dysentery

PubMed Health : 59
About infectious diarrhea: Diarrhea is very common: In Germany, for instance, adults get it once a year on average, and it is even more common in children. It is usually caused by viruses, the most common of which are the highly contagious norovirus and rotavirus. Infectious diarrhea can also come from bacteria such as Salmonella or Campylobacter.In normal cases of diarrhea, you can usually just replace the fluids you lose and wait until the infection goes away. But more severe or longer lasting diarrhea needs to be treated because it can lead to the loss of dangerously high levels of fluid and salt, especially in young children and older people.

MalaCards based summary : Dysentery, also known as infectious diarrhea, is related to shigellosis and appendicitis, and has symptoms including diarrhea An important gene associated with Dysentery is TF (Transferrin). The drugs Omeprazole and Azithromycin have been mentioned in the context of this disorder. Affiliated tissues include colon, liver and testes.

Disease Ontology : 12 An intestinal infectious disease that involves inflammation of the intestines, especially colon, due to chemical irritants, bacteria, protozoa, or parasitic worms, which results in severe diarrhea with passage of mucus and blood.

Wikipedia : 72 Dysentery is a type of gastroenteritis that results in diarrhea with blood. Other symptoms may include... more...

Related Diseases for Dysentery

Diseases related to Dysentery via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 162)
# Related Disease Score Top Affiliating Genes
1 shigellosis 32.2 CD79A LTF TTR
2 appendicitis 30.0 ALB CRP ENO2
3 iron deficiency anemia 29.8 CRP LTF TF
4 deficiency anemia 29.8 ALB CRP HP TF
5 malaria 29.4 ALB CRP HP IL1A TF
6 inflammatory bowel disease 29.0 ALB CD79A CRP IL1A LTF
7 protozoal dysentery 12.3
8 amebiasis 12.0
9 balantidiasis 11.5
10 campylobacteriosis 11.1
11 pyuria 10.5 ALB CRP
12 folic acid deficiency anemia 10.5 CRP TF
13 paramyloidosis 10.5 ALB TTR
14 acquired angioedema 10.5 CRP HP
15 median rhomboid glossitis 10.5 TF TTR
16 burns 10.5 ALB TTR
17 chronic inflammatory demyelinating polyneuropathy 10.5 HP TTR
18 congenital disorder of glycosylation, type ia 10.5 HP TF
19 bronchus cancer 10.5 CRP ENO2
20 aleutian mink disease 10.4 ALB TTR
21 miliary tuberculosis 10.4 CRP ENO2
22 amyloidosis aa 10.4 CRP TTR
23 chronic ulcer of skin 10.4 ALB TTR
24 ariboflavinosis 10.4 ALB TF
25 rheumatic myocarditis 10.4 CRP IL1A
26 hyperthyroxinemia 10.4 ALB TTR
27 tuberculous peritonitis 10.4 ALB CRP
28 superficial siderosis of the central nervous system 10.4 LTF TF
29 uremia 10.4 ALB CRP TF
30 superficial siderosis 10.4 LTF TF
31 cork-handlers' disease 10.4 ALB CD79A
32 ostertagiasis 10.4 ALB CD79A
33 chronic pulmonary heart disease 10.4 HP TTR
34 dermatitis, atopic, 3 10.4 ALB CD79A
35 kwashiorkor 10.4 ALB TF TTR
36 trypanosomiasis 10.4 ALB HP TF
37 orthostatic proteinuria 10.4 ALB CD79A
38 splenic disease 10.4 ALB IER3IP1
39 intestinal tuberculosis 10.4 CD79A CRP
40 decubitus ulcer 10.3 ALB CRP TTR
41 diarrhea 10.3
42 cryofibrinogenemia 10.3 CD79A HP
43 haemophilus influenzae 10.3 LTF TF
44 acute maxillary sinusitis 10.3 CD79A CRP
45 geniculate herpes zoster 10.3 CD79A HP
46 radiation proctitis 10.3 LTF TF
47 carotenemia 10.3 CD79A TTR
48 demyelinating polyneuropathy 10.3 ALB HP TTR
49 diffuse glomerulonephritis 10.3 ALB CD79A
50 respiratory failure 10.3 ALB CRP TTR

Comorbidity relations with Dysentery via Phenotypic Disease Network (PDN):

Acute Cystitis

Graphical network of the top 20 diseases related to Dysentery:

Diseases related to Dysentery

Symptoms & Phenotypes for Dysentery

UMLS symptoms related to Dysentery:


Drugs & Therapeutics for Dysentery

PubMedHealth treatment related to Dysentery: 59

You lose fluids and electrolytes when you have diarrhea, so it is important to replace them. For acute, non-severe diarrhea you usually just need something like tea with sugar and some salted crackers. Foods that are gentle on the stomach is recommended too, such as rice, bananas or rusk bread. Some people also avoid coffee, fruit juices, sodas, alcohol and fatty foods to keep from irritating their bowel even more.Acute, non-severe diarrhea does not require special treatment in adults and teenagers. But it is a good idea for young children and older people, as well as people with more severe diarrhea, to replace fluids and electrolytes by using oral rehydration salts (electrolyte/glucose solutions) from the pharmacy. These are powders containing salts, minerals and glucose that can be dissolved in water. If these solutions are not available (for instance, while traveling) the following ingredients can be stirred into one liter of bottled or boiled water:Five tablespoons of sugarOne and a half level tablespoons of saltOne glass of packaged orange juiceIn addition to drinking fluids and using other treatments, foods or dietary supplements that have probiotic microorganisms (probiotics) in them can help to make the diarrhea go away faster.Depending on how severe the symptoms are and how long they last, other treatments may be considered too:Drugs like loperamide or racecadotril can help to slow down the activity of the bowel and lower the number of times you need to go to the bathroom. Loperamide is not suitable for children under the age of twelve years, and racecadotril is prescription-only for children.Sometimes certain types of yeast tablets (Perenterol) are also recommended. These tablets are thought to help the body get rid of the germs faster and to support natural gut flora. Charcoal tablets dissolved in water can also be taken to relieve diarrhea symptoms. But there is a lack of good-quality research in this area so no conclusions can be drawn about the benefits and harms of these treatment options.Antibiotics are only an option if the infection is bacterial. They can't fight viruses.

Drugs for Dysentery (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 155)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
Azithromycin Approved Phase 4 83905-01-5 53477736 447043 55185
Loperamide Approved Phase 4,Phase 3 53179-11-6 3955
Rifaximin Approved, Investigational Phase 4,Phase 2,Phase 3 80621-81-4 6436173
Mebendazole Approved, Vet_approved Phase 4 31431-39-7 4030
Piperazine Approved, Vet_approved Phase 4 110-85-0 4837
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613 2171
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
9 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3
10 Anti-Infective Agents Phase 4,Phase 2,Phase 3
11 Antiparasitic Agents Phase 4,Phase 3,Phase 2
12 Antacids Phase 4,Phase 1
13 Anti-Ulcer Agents Phase 4,Phase 1
14 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Phase 1
15 Proton pump inhibitors Phase 4
16 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3
17 Antidiarrheals Phase 4,Phase 3
18 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3
19 rifamycin SV Phase 4,Phase 2,Phase 3
20 Rifamycins Phase 4,Phase 2,Phase 3
21 Anthelmintics Phase 4
22 Antimitotic Agents Phase 4
23 Piperazine citrate Phase 4
24 Amoxicillin-Potassium Clavulanate Combination Phase 4
25 Antitubercular Agents Phase 4,Phase 3
26 beta-Lactamase Inhibitors Phase 4
27 Clavulanic Acid Phase 4
28 Acidophilus Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2
29 Cola Nutraceutical Phase 4
30 Citrate Nutraceutical Phase 4
Ciprofloxacin Approved, Investigational Phase 3,Phase 2 85721-33-1 2764
Iron Approved Phase 3,Phase 2 7439-89-6 23925
Zinc Approved, Investigational Phase 3,Phase 2 7440-66-6 32051 23994
34 Zinc sulfate Approved, Investigational Phase 3 7733-02-0
Nitazoxanide Approved, Investigational, Vet_approved Phase 3,Phase 2 55981-09-4 41684
Terlipressin Approved, Investigational Phase 3 14636-12-5 72081
Lactulose Approved Phase 2, Phase 3 4618-18-2 11333
Irinotecan Approved, Investigational Phase 3 97682-44-5, 100286-90-6 60838
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
leucovorin Approved, Nutraceutical Phase 3 58-05-9 143 6006
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3 68-26-8, 11103-57-4 445354
42 Cytochrome P-450 CYP1A2 Inhibitors Phase 3,Phase 2
43 Cytochrome P-450 Enzyme Inhibitors Phase 3,Phase 2
44 Topoisomerase Inhibitors Phase 3,Phase 2
45 Antirheumatic Agents Phase 3,Phase 2,Phase 1
46 Antibodies Phase 3
47 Immunoglobulins Phase 3
48 Vaccines Phase 3,Phase 1,Phase 2
49 Micronutrients Phase 3,Phase 2
50 Trace Elements Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 97)

# Name Status NCT ID Phase Drugs
1 New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management– Surveillance Study for Adverse Effects Completed NCT00490932 Phase 4 Hypo-osmolar ORS
2 Effects of Gastric Acid on Colonic Microbiome Completed NCT01901276 Phase 4 Omeprazole 40 mg bid
3 Azithromycin, With or Without Loperamide, to Treat Travelers' Diarrhea Completed NCT00359970 Phase 4 Azithromycin 500 mg;Azithromycin 1000 mg;Loperamide
4 Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea Completed NCT00292344 Phase 4 Rifaximin and loperamide
5 Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population Completed NCT02385058 Phase 4 Mebendazole;Quinfamide;Placebo
6 Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children Recruiting NCT02765217 Phase 4 Lactobacillus reuteri DSM 17938;Placebo;Amoxicillin-Clavulanic Acid
7 Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial Recruiting NCT02871908 Phase 4 Lactobacillus reuteri DSM 17938;Placebo
8 Improving Bowel Habits of Elderly With Probiotics and Non-probiotics Not yet recruiting NCT02949882 Phase 4
9 Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea Terminated NCT01972932 Phase 4
10 Probiotics and the Prevention of Traveler's Diarrhea Terminated NCT01005849 Phase 4
11 Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea Withdrawn NCT00875875 Phase 4 Rifaximin
12 Randomized Controlled Field Trial of a Probiotics to Assess Its Role in Preventig Diarrhoea Unknown status NCT00534170 Phase 3
13 Efficacy of Rifaximin in Preventing Campylobacteriosis Completed NCT02280044 Phase 2, Phase 3
14 Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea Completed NCT01208922 Phase 3 Rifamycin SV MMX;Ciprofloxacin
15 Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel Completed NCT00368316 Phase 3
16 Impact of Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly Prevalent Completed NCT00530374 Phase 3
17 Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal Completed NCT00109551 Phase 3 zinc sulphate dietary supplement;iron sulphate-folic acid dietary supplement
18 Fermented Milk and Fermented Rice on the Appearance of Respiratory and Gastrointestinal Symptoms Completed NCT01909128 Phase 3
19 Vitamin A Supplementation in Newborns Study Completed NCT00114868 Phase 3 Vitamin A
20 Zinc Supplementation in Shigella Patients Completed NCT00321126 Phase 3 Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks.
21 Study of Nitazoxanide in the Treatment of Amebiasis in Children Completed NCT00366730 Phase 3 Nitazoxanide
22 Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents Completed NCT00366236 Phase 3 Nitazoxanide
23 Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD) Completed NCT01142089 Phase 3 Placebo;Rifamycin SV MMX
24 Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study Completed NCT00993681 Phase 3
25 Rifaximin for Prevention of Travellers' Diarrhea Completed NCT00742469 Phase 3 Rifaximin;Placebo
26 Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in Adults Completed NCT00737412 Phase 3
27 Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S. Completed NCT00328380 Phase 3 Rifaximin
28 Comparison of Bovine Colostrum Versus Placebo in Treatment of Severe Alcoholic Hepatitis: A Randomized Double Blind Controlled Trial Recruiting NCT02473341 Phase 3 Bovine Colostrum;Placebo
29 Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy Recruiting NCT02464124 Phase 2, Phase 3 Nitazoxanide;Lactulose
30 Prevention of Irinotecan Induced Diarrhea by Probiotics Recruiting NCT02819960 Phase 3 PROBIO-FIX INUM®;Placebo
31 A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea. Terminated NCT02920242 Phase 3 Rifaximin (Sandoz GmbH) tablet;Rifaximin (Xifaxan);Placebo
32 A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea Terminated NCT00466635 Phase 3 GT267-004 (tolevamer potassium sodium)
33 Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea Withdrawn NCT02736539 Phase 3 CBS 2004 (galacto-oligosaccharides);Placebo
34 A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans Unknown status NCT01243437 Phase 2 ciprofloxacin;doxyxcycline
35 Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea Completed NCT03447821 Phase 2 400 mg Rifamycin SV dosage;800 mg Rifamycin SV dosage;1200 mg Rifamycin SV dosage
36 Probiotics for Infectious Diarrhea in Children in South India Completed NCT01130792 Phase 1, Phase 2
37 Isoleucine Added ORS in Children With Diarrhoea Completed NCT01034228 Phase 2
38 Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection Completed NCT00485134 Phase 1, Phase 2
39 Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate Completed NCT01080716 Phase 1, Phase 2
40 Effect of Irvingia Gabonensis Administration on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity Completed NCT02354339 Phase 2
41 A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults Completed NCT02676895 Phase 2
42 Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a Completed NCT02646371 Phase 2
43 Therapeutic Induction of Endogenous Antibiotics Completed NCT00800930 Phase 2
44 Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine Completed NCT00210288 Phase 2
45 Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis. Completed NCT02265328 Phase 2
46 Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study Completed NCT01040325 Phase 2
47 Traveler's Diarrhea (TD) Automated Process Completed NCT00751777 Phase 2
48 Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea Completed NCT00098384 Phase 2 rifaximin
49 A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea Completed NCT00382304 Phase 2 tolevamer potassium-sodium (GT267-004)
50 A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea Completed NCT00034294 Phase 2 GT160-246

Search NIH Clinical Center for Dysentery

Inferred drug relations via UMLS 69 / NDF-RT 47 :

Cochrane evidence based reviews: dysentery

Genetic Tests for Dysentery

Anatomical Context for Dysentery

MalaCards organs/tissues related to Dysentery:

Colon, Liver, Testes, Neutrophil, Bone Marrow, Small Intestine, Bone

Publications for Dysentery

Articles related to Dysentery:

(show top 50) (show all 588)
# Title Authors Year
Occurrence of dysentery-like diarrhoea associated with<i>Brachyspira suanatina</i>infection in a German fattening pig farm. ( 29419486 )
The other Campylobacters: Not innocent bystanders in endemic diarrhea and dysentery in children in low income settings. ( 29415075 )
<i>Shigella</i> phages isolated during a dysentery outbreak reveal uncommon structures and broad species diversity. ( 29437962 )
Spatial-temporal detection of risk factors for bacillary dysentery in Beijing, Tianjin and Hebei, China. ( 28946856 )
Impact of meteorological factors on the incidence of bacillary dysentery in Beijing, China: A time series analysis (1970-2012). ( 28796834 )
Antibiotic Therapy for Acute Watery Diarrhea and Dysentery. ( 28885920 )
An avirulent Brachyspira hyodysenteriae strain elicits intestinal IgA and slows down spread of swine dysentery. ( 28982389 )
Impacts of ambient temperature on the burden of bacillary dysentery in urban and rural Hefei, China. ( 28294081 )
The Role of Probiotics in the Treatment of Dysentery: a Randomized Double-Blind Clinical Trial. ( 28321826 )
Assessment on the burden of bacillary dysentery associated with floods during 2005-2009 in Zhengzhou City, China, using a time-series analysis. ( 29100875 )
Comparison of the Luminal and Mucosa-Associated Microbiota in the Colon of Pigs with and without Swine Dysentery. ( 28971100 )
The Effects of Floods on the Incidence of Bacillary Dysentery in Baise (Guangxi Province, China) from 2004 to 2012. ( 28208681 )
Environmental Drivers and Predicted Risk of Bacillary Dysentery in Southwest China. ( 28708077 )
A cohort study of the effect of winter dysentery on herd-level milk production. ( 28601443 )
Spatiotemporal Risk of Bacillary Dysentery and Sensitivity to Meteorological Factors in Hunan Province, China. ( 29286297 )
Residential proximity to high-density poultry operations associated with campylobacteriosis and infectious diarrhea. ( 29268955 )
Identification of weather variables sensitive to dysentery in disease-affected county of China. ( 27742060 )
The dysentery epidemic in Poland in 1920-1921 ( 28742314 )
Seasonal and geographical distribution of bacillary dysentery (shigellosis) and associated climate risk factors in Kon Tam Province in Vietnam from 1999 to 2013. ( 28637484 )
Geraniol as a novel antivirulence agent against bacillary dysentery-causing Shigella sonnei. ( 29256316 )
Projected burden of disease for bacillary dysentery due to flood events in Guangxi, China. ( 28605848 )
Treatment rates for injectable tiamulin and lincomycin as an estimate of morbidity in a swine herd with endemic swine dysentery. ( 28487591 )
Antiprotozoal Constituents from Annona cherimola Miller, a Plant Used in Mexican Traditional Medicine for the Treatment of Diarrhea and Dysentery. ( 28216899 )
An optimized swine dysentery murine model to characterize shedding and clinical disease associated with "Brachyspira hampsonii" infection. ( 28830508 )
A novel multiplex qPCR targeting 23S rDNA for diagnosis of swine dysentery and porcine intestinal spirochaetosis. ( 28173799 )
Distributed lag effects and vulnerable groups of floods on bacillary dysentery in Huaihua, China. ( 27427387 )
Quantifying the Impact of Floods on Bacillary Dysentery in Dalian City, China, From 2004 to 2010. ( 27229186 )
An Investigation into the Etiological Agents of Swine Dysentery in Australian Pig Herds. ( 27907102 )
Clinical study on the efficacy of Amoebex (coded herbal drug) compared with Metronidazole for the treatment of Amoebic dysentery. ( 28375117 )
The Use of an Autoregressive Integrated Moving Average Model for Prediction of the Incidence of Dysentery in Jiangsu, China. ( 27106828 )
Comparison of Brachyspira hyodysenteriae Isolates Recovered from Pigs in Apparently Healthy Multiplier Herds with Isolates from Herds with Swine Dysentery. ( 27489956 )
The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014. ( 27863468 )
Low Prevalence of Aeromonas hydrophilain Infectious Diarrhea Samples of Pediatric Patients in Arak, Iran. ( 28070529 )
Epidemiologic Investigation of Dysentery in North of Iran: Use of Geographic Information System (GIS). ( 28144197 )
Lethality of First Contact Dysentery Epidemics on Pacific Islands. ( 27185765 )
Patterns of Bacillary Dysentery in China, 2005-2010. ( 26828503 )
Neither plague nor malaria, but dysentery as a cause of death for St. Louis. ( 26759133 )
Swine Dysentery: Etiopathogenesis and Diagnosis of a Reemerging Disease. ( 27288432 )
Anisakiasis Causing Acute Dysentery in Malaysia. ( 27325803 )
Quantitative analysis of burden of bacillary dysentery associated with floods in Hunan, China. ( 26780145 )
Association between flood and the morbidity of bacillary dysentery in Zibo City, China: a symmetric bidirectional case-crossover study. ( 27121465 )
Daily temperature change in relation to the risk of childhood bacillary dysentery among different age groups and sexes in a temperate city in China. ( 26655018 )
Efficacy of Synbiotics for Treatment of Bacillary Dysentery in Children: A Double-Blind, Randomized, Placebo-Controlled Study. ( 28042600 )
Association between meteorological factors and bacillary dysentery incidence in Chaoyang city, China: an ecological study. ( 27940632 )
Burden of major diarrheagenic protozoan parasitic co-infection among amoebic dysentery cases from North East India: a case report. ( 26099490 )
The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery. ( 26068698 )
High mean water vapour pressure promotes the transmission of bacillary dysentery. ( 25946209 )
Analysis of Risk and Burden of Dysentery Associated with Floods from 2004 to 2010 in Nanning, China. ( 26416103 )
The association between diurnal temperature range and childhood bacillary dysentery. ( 26045331 )
Spatio-Temporal Pattern and Socio-Economic Factors of Bacillary Dysentery at County Level in Sichuan Province, China. ( 26469274 )

Variations for Dysentery

Expression for Dysentery

Search GEO for disease gene expression data for Dysentery.

Pathways for Dysentery

GO Terms for Dysentery

Cellular components related to Dysentery according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.76 ALB CRP ENO2 HP LTF PHB2
2 extracellular region GO:0005576 9.61 ALB CRP HP IFNA2 IL1A LTF
3 extracellular space GO:0005615 9.32 ALB CRP ENO2 HP IFNA2 IL1A

Biological processes related to Dysentery according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular protein metabolic process GO:0044267 9.26 ALB LTF TF TTR
2 retina homeostasis GO:0001895 8.8 ALB LTF TF

Molecular functions related to Dysentery according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 antioxidant activity GO:0016209 8.62 ALB HP

Sources for Dysentery

9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
31 HPO
32 ICD10
33 ICD10 via Orphanet
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
51 Novoseek
54 OMIM via Orphanet
58 PubMed
66 SNOMED-CT via Orphanet
68 Tocris
70 UMLS via Orphanet
Loading form....